UBS Preps Acqui Deal

Harlan Sprague Dawley has tapped the loan market for financing to back its acquisition of SafePharm. UBS leads the loans, which consist of a six-year, $30 million super-priority revolver divided between U.S. dollars and euros, and a seven-year, $330 million first-lien term loan. Pricing is LIBOR plus 2 ...